Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer

Clinical trial NCT03146650 · UNKNOWN

Trial details

NCT number: NCT03146650
Sponsor: Northwestern University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Major Salivary Gland Carcinoma Minor Salivary Gland Carcinoma Recurrent Salivary Gland Carcinoma Stage IV Major Salivary Gland Carcinoma Stage IVA Major Salivary Gland Carcinoma Stage IVB Major Salivary Gland Carcinoma Stage IVC Major Salivary Gland Carcinoma

Start date: 2017-05-19
Primary completion: 2021-02-24
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.